Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure

Science Translational Medicine

Volumn 5, Issue 175, 2013, Pages

  Berg, Anders H ^a   Drechsler, Christian ^b   Wenger, Julia ^c   Buccafusca, Roberto ^d,e   Hod, Tammy ^d   Kalim, Sahir ^c   Ramma, Wenda ^a   Parikh, Samir M ^d   Steen, Hanno ^e   Friedman, David J ^d   Danziger, John ^d   Wanner, Christoph ^b   Thadhani, Ravi ^c   Karumanchi, S Ananth ^d,f  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; CYANIC ACID; CYSTEINE; HISTIDINE; LYSINE; NUCLEOPHILE; SERUM ALBUMIN; TAURINE; UREA;

AMINO ACID BLOOD LEVEL; AMINO ACID DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBAMOYLATION; CONTROLLED STUDY; DEATH; DIABETIC PATIENT; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MORTALITY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN MODIFICATION; RISK FACTOR; SURVIVAL TIME; TEMPERATURE; UREA BLOOD LEVEL; UREMIA;

AMINO ACIDS; HUMANS; KIDNEY FAILURE, CHRONIC; RISK FACTORS; SERUM ALBUMIN;

EID: 84875165511     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005218     Document Type: Article

References (54)

1. G. Eknoyan, N. Lameire, R. Barsoum, K. U. Eckardt, A. Levin, N. Levin, F. Locatelli, A. MacLeod, R. Vanholder, R. Walker, H. Wang, The burden of kidney disease: Improving global outcomes. Kidney Int. 66, 1310-1314 (2004). (Pubitemid 39302630)
2. R. N. Foley, P. S. Parfrey, M. J. Sarnak, Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 32, S112-S119 (1998). (Pubitemid 28527268)
3. United States Renal Data System, 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2009).
4. C. Wanner, V. Krane, W. Marz, M. Olschewski, J. F. Mann, G. Ruf, E. Ritz; German Diabetes and Dialysis Study Investigators, Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N. Engl. J. Med. 353, 238-248 (2005). (Pubitemid 41058323)
5. B. C. Fellström, A. G. Jardine, R. E. Schmieder, H. Holdaas, K. Bannister, J. Beutler, D. W. Chae, A. Chevaile, S. M. Cobbe, C. Grönhagen-Riska, J. J. De Lima, R. Lins, G. Mayer, A. W. McMahon, H. H. Parving, G. Remuzzi, O. Samuelsson, S. Sonkodi, D. Sci, G. Süleymanlar, D. Tsakiris, V. Tesar, V. Todorov, A. Wiecek, R. P. Wuthrich, M. Gottlow, E. Johnsson, F. Zannad; AURORA Study Group, Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N. Engl. J. Med. 360, 1395-1407 (2009).
6. S. A. Karumanchi, R. Thadhani, Kidney complications: Why don't statins always work? Nat. Med. 16, 38-40 (2010).
7. W. J. Johnson, W. W. Hagge, R. D. Wagoner, R. P. Dinapoli, J. W. Rosevear, Effects of urea loading in patients with far-advanced renal failure. Mayo Clin. Proc. 47, 21-29 (1972).
8. G.M. Chertow,W. F.Owen, J.M. Lazarus,N. L. Lew, E. G. Lowrie, Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int. 56, 1872-1878 (1999). (Pubitemid 29518188)
9. M. Stosovic, M. Stanojevic, S. Simic-Ogrizovic, D. Jovanovic, L. Djukanovic, Relation between serum urea and mortality of hemodialysis patients. Ren. Fail. 31, 335-340 (2009).
10. G. Eknoyan, G. J. Beck, A. K. Cheung, J. T. Daugirdas, T. Greene, J. W. Kusek, M. Allon, J. Bailey, J. A. Delmez, T. A. Depner, J. T. Dwyer, A. S. Levey, N. W. Levin, E. Milford, D. B. Ornt, M. V. Rocco, G. Schulman, S. J. Schwab, B. P. Teehan, R. Toto; Hemodialysis (HEMO) Study Group, Effect of dialysis dose and membrane flux in maintenance hemodialysis. N. Engl. J. Med. 347, 2010-2019 (2002). (Pubitemid 35461657)
11. Z.Wang, S. J. Nicholls, E. R. Rodriguez, O. Kummu, S. Hörkkö, J. Barnard, W. F. Reynolds, E. J. Topol, J. A. DiDonato, S. L. Hazen, Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat. Med. 13, 1176-1184 (2007). (Pubitemid 47530630)
12. E. O. Apostolov, D. Ray, A. V. Savenka, S. V. Shah, A. G. Basnakian, Chronic uremia stimulates LDL carbamylation and atherosclerosis. J. Am. Soc. Nephrol. 21, 1852-1857 (2010).
13. R. Flückiger, W. Harmon, W. Meier, S. Loo, K. H. Gabbay, Hemoglobin carbamylation in uremia. N. Engl. J. Med. 304, 823-827 (1981). (Pubitemid 11147484)
14. M. Oimomi, K. Ishikawa, T. Kawasaki, S. Kubota, Y. Yoshimura, S. Baba, Plasma carbamylated protein in renal failure. N. Engl. J. Med. 308, 655-656 (1983).
15. G. R. Stark, W. H. Stein, S. Moore, Reactions of the cyanate present in aqueous urea with amino acids and proteins. J. Biol. Chem. 235, 3177-3181 (1960).
16. D. M. Nathan, J. Kuenen, R. Borg, H. Zheng, D. Schoenfeld, R. J. Heine; A1c-Derived Average Glucose Study Group, Translating the A1C assay into estimated average glucose values. Diabetes Care 31, 1473-1478 (2008).
17. A. Frolov, R. Hoffmann, Identification and relative quantification of specific glycation sites in human serum albumin. Anal. Bioanal. Chem. 397, 2349-2356 (2010).
18. S. M. Brunelli, R. I. Thadhani, K. E. Lynch, E. D. Ankers, M. M. Joffe, R. Boston, Y. Chang, H. I. Feldman, Association between long-term blood pressure variability and mortality among incident hemodialysis patients. Am. J. Kidney Dis. 52, 716-726 (2008).
19. O. M. Gutiérrez, M. Mannstadt, T. Isakova, J. A. Rauh-Hain, H. Tamez, A. Shah, K. Smith, H. Lee, R. Thadhani, H. Jüppner, M. Wolf, Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N. Engl. J. Med. 359, 584-592 (2008).
20. B. Rosner, Fundamentals of Biostatistics (Duxbury Press, Belmont, CA, ed. 6, 2006).
21. J. P. Klein, M. L. Moeschberger, Survival Analysis: Techniques for Censored and Truncated Data (Springer, New York, ed. 2, 2003).
22. T. Depner, G. Beck, J. Daugirdas, J. Kusek, G. Eknoyan, Lessons from the Hemodialysis (HEMO) Study: An improvedmeasure of the actual hemodialysis dose. Am. J. Kidney Dis. 33, 142-149 (1999). (Pubitemid 29031223)
23. C. Wanner, V. Krane, W. März, M. Olschewski, H. G. Asmus, W. Krämer, K. W. Kühn, H. Kütemeyer, J. F. Mann, G. Ruf, E. Ritz; Deutsche Diabetes-Dialyse-Studie (4D) Study Group, Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): Demographic and baseline characteristics. Kidney Blood Press. Res. 27, 259-266 (2004). (Pubitemid 39279330)
24. B. Yang, L. Bankir, Urea and urine concentrating ability: New insights from studies in mice. Am. J. Physiol. Renal Physiol. 288, F881-F896 (2005). (Pubitemid 40569752)
25. P. Goldwasser, N. Mittman, A. Antignani, D. Burrell, M. A. Michel, J. Collier, M. M. Avram, Predictors of mortality in hemodialysis patients. J. Am. Soc. Nephrol. 3, 1613-1622 (1993).
26. S. Malgorzewicz, A. Debska-Slizien, B. Rutkowski, W. Lysiak-Szydlowska, Serum concentration of amino acids versus nutritional status in hemodialysis patients. J. Ren. Nutr. 18, 239-247 (2008). (Pubitemid 351215227)
27. E. O. Apostolov, S. V. Shah, E. Ok, A. G. Basnakian, Carbamylated low-density lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Arterioscler. Thromb. Vasc. Biol. 27, 826-832 (2007). (Pubitemid 46606713)
28. E. O. Apostolov, S. V. Shah, D. Ray, A. G. Basnakian, Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL. Arterioscler. Thromb. Vasc. Biol. 29, 1622-1630 (2009).
29. G. Asci, A. Basci, S. V. Shah, A. Basnakian, H. Toz, M. Ozkahya, S. Duman, E. Ok, Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells. Nephrology 13, 480-486 (2008).
30. C. M. Balion, T. F. Draisey, R. J. Thibert, Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients. Kidney Int. 53, 488-495 (1998). (Pubitemid 28097868)
31. J. Carracedo, A. Merino, C. Briceño, S. Soriano, P. Buendía, L. Calleros, M. Rodriguez, A. Martín-Malo, P. Aljama, R. Ramírez, Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. FASEB J. 25, 1314-1322 (2011).
32. S. Jaisson, C. Delevallée-Forte, F. Touré, P. Rieu, R. Garnotel, P. Gillery, Carbamylated albumin is a potent inhibitor of polymorphonuclear neutrophil respiratory burst. FEBS Lett. 581, 1509-1513 (2007). (Pubitemid 46463961)
33. L. M. Kraus, M. R. Jones, A. P. Kraus Jr., Essential carbamoyl-amino acids formed in vivo in patients with end-stage renal disease managed by continuous ambulatory peritoneal dialysis: Isolation, identification, and quantitation. J. Lab. Clin. Med. 131, 425-431 (1998). (Pubitemid 28259758)
34. L. M. Kraus, A. P. Kraus Jr., Carbamoylation of amino acids and proteins in uremia. Kidney Int. Suppl. 78, S102-S107 (2001). (Pubitemid 32144080)
35. E. Ok, A. G. Basnakian, E. O. Apostolov, Y. M. Barri, S. V. Shah, Carbamylated low-density lipoprotein induces death of endothelial cells: A link to atherosclerosis in patients with kidney disease. Kidney Int. 68, 173-178 (2005). (Pubitemid 43181374)
36. G. R. Stark, On the reversible reaction of cyanate with sulfhydryl groups and the determination of NH2-terminal cysteine and cystine in proteins. J. Biol. Chem. 239, 1411-1414 (1964).
37. G. R. Stark, Reactions of cyanate with functional groups of proteins. 3. Reactions with amino and carboxyl groups. Biochemistry 4, 1030-1036 (1965).
38. G. R. Stark, Reactions of cyanate with functional groups of proteins. IV. Inertness of aliphatic hydroxyl groups. Formation of carbamyl- and acylhydantoins. Biochemistry 4, 2363-2367 (1965).
39. G. R. Stark, Reactions of cyanate with functional groups of proteins. II. Formation, decomposition, and properties of N-carbamylimidazole. Biochemistry 4, 588-595 (1965).
40. G. R. Stark, D. G. Smyth, The use of cyanate for the determination of NH2-terminal residues in proteins. J. Biol. Chem. 238, 214-226 (1963).
41. S. Jaisson, C. Pietrement, P. Gillery, Carbamylation-derived products: Bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis. Clin. Chem. 57, 1499-1505 (2011).
42. R. Paniagua, D. Amato, E. Vonesh, R. Correa-Rotter, A. Ramos, J. Moran, S. Mujais; Mexican Nephrology Collaborative Study Group, Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J. Am. Soc. Nephrol. 13, 1307-1320 (2002). (Pubitemid 34441412)
43. L. Elangovan, C. S. Shinaberger, J. A. Kraut, J. H. Shinaberger, HEMO equilibrated Kt/V goals are difficult to achieve in large male patients. ASAIO J. 47, 235-239 (2001). (Pubitemid 32423010)
44. J. C. Ayus, M. R. Mizani, S. G. Achinger, R. Thadhani, A. S. Go, S. Lee, Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J. Am. Soc. Nephrol. 16, 2778-2788 (2005).
45. R. P. Pauly, Nocturnal home hemodialysis and short daily hemodialysis compared with kidney transplantation: Emerging data in a new era. Adv. Chronic Kidney Dis. 16, 169-172 (2009).
46. R. A. Koeth, K. Kalantar-Zadeh, Z. Wang, S. L. Hazen, Abstract 1496: Protein bound homocitrulline independently predicts mortality risks in maintenance hemodialysis patients. Circulation 118, S337 (2008).
47. M. L. Gross, G. Piecha, A. Bierhaus, W. Hanke, T. Henle, P. Schirmacher, E. Ritz, Glycated and carbamylated albumin are more "nephrotoxic" than unmodified albumin in the amphibian kidney. Am. J. Physiol. Renal Physiol. 301, F476-F485 (2011).
48. S. M. Schreier, M. Hollaus, M. Hermann, L. Jirovetz, M. Exner, S. Kapiotis, B. M. Gmeiner, H. Laggner, Carbamoylated free amino acids in uremia: HOCl generates volatile protein modifying and cytotoxic oxidant species from N-carbamoyl-threonine but not threonine. Biochimie 94, 2441-2447 (2012).
49. J. C. Fish, A. R. Remmers Jr., J. D. Lindley, H. E. Sarles, Albumin kinetics and nutritional rehabilitation in the unattended home-dialysis patient. N. Engl. J. Med. 287, 478-481 (1972).
50. D. J. Friedman, M. Afkarian, H. Tamez, I. Bhan, T. Isakova, M. Wolf, E. Ankers, J. Ye, M. Tonelli, C. Zoccali, M. Kuro-o, O. Moe, S. A. Karumanchi, R. Thadhani, Klotho variants and chronic hemodialysis mortality. J. Bone Miner. Res. 24, 1847-1855 (2009).
51. S. Lin, T. A. Shaler, C. H. Becker, Quantification of intermediate-abundance proteins in serum by multiple reaction monitoring mass spectrometry in a single-quadrupole ion trap. Anal. Chem. 78, 5762-5767 (2006). (Pubitemid 44265037)
52. J. E. Antflick, G. B. Baker, D. R. Hampson, The effects of a low protein diet on amino acids and enzymes in the serine synthesis pathway in mice. Amino Acids 39, 145-153 (2010).
53. J. Tor-Agbidye, V. S. Palmer, P. S. Spencer, A. M. Craig, L. L. Blythe, M. I. Sabri, Sodium cyanate alters glutathione homeostasis in rodent brain: Relationship to neurodegenerative diseases in protein-deficient malnourished populations in Africa. Brain Res. 820, 12-19 (1999). (Pubitemid 29225474)
54. I. V. Shilov, S. L. Seymour, A. A. Patel, A. Loboda, W. H. Tang, S. P. Keating, C. L. Hunter, L. M. Nuwaysir, D. A. Schaeffer, The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell. Proteomics 6, 1638-1655 (2007). (Pubitemid 47506173)